Crinetics Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount
Crinetics Pharmaceuticals, Inc. (CRNX) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount of $53.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxSettlementsForeign · last filed 2025-02-27
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax settlement, foreign, amount for fiscal 2024 was $53.00K, a 51.43% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax settlement, foreign, amount for fiscal 2023 was $35.00K, a 86.84% decline from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax settlement, foreign, amount for fiscal 2022 was $266.00K, a 885.19% increase from fiscal 2021.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax settlement, foreign, amount for fiscal 2021 was $27.00K, a 87.44% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount 12 month |
|---|---|
| 2024-12-31 | $53.00K 10-K · filed 2025-02-27 |
| 2023-12-31 | $35.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $266.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $27.00K 10-K · filed 2024-02-28 |
| 2020-12-31 | $215.00K 10-K · filed 2023-02-28 |
| 2019-12-31 | $307.00K 10-K · filed 2022-03-30 |
| 2018-12-31 | $362.00K 10-K · filed 2021-03-30 |
| 2017-12-31 | $176.00K 10-K · filed 2020-03-09 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-13 |